NNE Pharmaplan is part of the consortium called Indigo, which was yesterday announced as the winning team for a new hospital project in Aalborg, Denmark.
The total investment cost for the project is DKK 4,1 billion (approximately EUR 0.5 billion). The project will start up in 2013 and the hospital is expected to be inaugurated in 2020.
New business unit for Healthcare & Labs
NNE Pharmaplan has recently established a new business unit with dedicated focus on healthcare.
“Our know-how from pharmaceutical and biotech environments can be brought to excellent use in the facility design and engineering of hospitals and laboratories. We supply interdisciplinary architectural, engineering and consultancy services ensuring optimal design solutions for a healthier world. The win of Aalborg New University Hospital is a significant milestone in putting NNE Pharmaplan on the Danish healthcare map”, says Jesper Videsen, General Manager for the new business unit.
About the Indigo consortium
Besides NNE Pharmaplan, Indigo consists of Aarhus Arkitekterne, Schmidt Hammer Lassen Architects, Creo Arkitekter, Oluf Jørgensen Rådgivende Ingeniørfirma, Royal Haskoning and Brix & Kamp Rådgivende Ingeniørvirksomhed. In addition, Norconsult, Implement , Arkitekterne Bjørk & Maigaard and Arkitekt Kristine Jensens Tegnestue will act as sub-suppliers.
Read the official press release (in Danish only) for more information.
General Manager, Healthcare & Labs
Phone: +45 30797149